These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Valproate-associated hyperammonemic encephalopathy. Report of one case]. Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656 [TBL] [Abstract][Full Text] [Related]
3. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting]. Fassi G; Igoa A; Liste OA Vertex; 2008; 19(82):371-7. PubMed ID: 19424520 [TBL] [Abstract][Full Text] [Related]
4. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate]. Mattei A; Bernard G; Plauchu G; Paliard P Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949 [No Abstract] [Full Text] [Related]
5. A case of valproate-induced hyperammonaemic encephalopathy. Lucie O; Nazir F; Spilg E Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040 [TBL] [Abstract][Full Text] [Related]
9. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate]. Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198 [No Abstract] [Full Text] [Related]
11. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy. Izadi Firouzabadi L; Geer K; Mead P; Postgrad Med J; 2018 Nov; 94(1117):664. PubMed ID: 30397004 [No Abstract] [Full Text] [Related]
12. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate. Deutsch SI; Burket JA; Rosse RB Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878 [TBL] [Abstract][Full Text] [Related]
13. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient. Abreu LN; Issler C; Lafer B Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315 [No Abstract] [Full Text] [Related]
19. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting. Dawson LP; Lee SJ; Hollander YS Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174 [No Abstract] [Full Text] [Related]
20. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children. Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]